World Health Organization. WHO European Regional Obesity Report 2022. 2022. https://www.who.int/europe/publications/i/item/9789289057738. Accessed 28 Nov 2022.
Baker C Obesity statistics. In: House of Commons Library. Research Briefing. 2023. https://commonslibrary.parliament.uk/research-briefings/sn03336/. Accessed 15 Feb 2023.
Donini LM, Rosano A, Di Lazzaro L, Lubrano C, Carbonelli M, Pinto A, et al. Impact of disability, psychological status, and comorbidity on health-related quality of life perceived by subjects with obesity. Obes Facts. 2020;13:191–200.
Tobias DK, Hu FB. The association between BMI and mortality: implications for obesity prevention. Lancet Diabetes Endocrinol. 2018;6:916–7.
Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022;18:1345–56.
National Institute of Health and Care Excellence. Obesity: identification, assessment and management (CG189). 2022. https://www.nice.org.uk/guidance/cg189. Accessed 7 Jan 2023.
National Institute of Health and Care Excellence. Final Scope. In: Weight management: preventing, assessing and managing overweight and obesity (update). In development [GID-NG10182]. 2021. https://www.nice.org.uk/guidance/indevelopment/gid-ng10182/documents. Accessed 18 Nov 2022.
National Bariatric Surgery Registry. The UK National Bariatric Surgery Registry Third Registry Report. 2020. https://www.e-dendrite.com/NBSR2020. Accessed 18 Nov 2022.
Beran A, Matar R, Jaruvongvanich V, Rapaka BB, Alalwan A, Portela R, et al. Comparative effectiveness and safety between endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a meta-analysis of 6775 individuals with obesity. Obes Surg. 2022;32:3504–12.
Queally M, Doherty E, Finucane F, O’Neill C. Preferences for weight loss treatment amongst treatment-seeking patients with severe obesity: a discrete choice experiment. Appl Health Econ Health Policy. 2020;18:689–98.
Desogus D, Menon V, Singhal R, Oyebode O. An examination of who is eligible and who is receiving bariatric surgery in england: secondary analysis of the health survey for England dataset. Obes Surg. 2019;29:3246–51.
Pillutla V, Maslen H, Savulescu J. Rationing elective surgery for smokers and obese patients: responsibility or prognosis? BMC Med Ethics. 2018;19:28.
Owen-Smith A, Coast J, Donovan JL. Self-responsibility, rationing and treatment decision making – managing moral narratives alongside fiscal reality in the obesity surgery clinic. Health Expect. 2018;21:606–14.
Abu Dayyeh BK, Bazerbachi F, Vargas EJ, Sharaiha RZ, Thompson CC, Thaemert BC, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022;400:441–51.
de Miranda Neto AA, de Moura DTH, Ribeiro IB, Khan A, Singh S, da Ponte Neto AM, et al. Efficacy and safety of endoscopic sleeve gastroplasty at mid term in the management of overweight and obese patients: a systematic review and meta-analysis. Obes Surg. 2020;30:1971–87.
Hedjoudje A, Abu Dayyeh BK, Cheskin LJ, Adam A, Neto MG, Badurdeen D, et al. Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020;18:1043–53.e4.
National Institute of Health and Care Excellence. Endoscopic sleeve gastroplasty for severe obesity. In development [GID-IPG10300]. 2022. https://www.nice.org.uk/guidance/indevelopment/gid-ipg10300.
Avenell A, Robertson C, Skea Z, Jacobsen E, Boyers D, Cooper D, et al. Bariatric surgery, lifestyle interventions and orlistat for severe obesity: the REBALANCE mixed-methods systematic review and economic evaluation. Health Technol Assess. 2018;22:1–246.
Boyers D, Retat L, Jacobsen E, Avenell A, Aveyard P, Corbould E, et al. Cost-effectiveness of bariatric surgery and non-surgical weight management programmes for adults with severe obesity: a decision analysis model. Int J Obes (Lond). 2021;45:2179–90.
National Institute of Health and Care Excellence. NICE health technology evaluations: the manual. 2022. https://www.nice.org.uk/process/pmg36/resources/. Accessed 18 Nov 2022.
Gandjour A. Willingness to pay for new medicines: a step towards narrowing the gap between NICE and IQWiG. BMC Health Serv Res. 2020;20:343.
Husereau D, Drummond M, Augustovski F, de Bekker-Grob E, Briggs AH, Carswell C, et al. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations. BMJ. 2022;376:e067975.
Apollo Endosurgery Inc. MERIT trial patient-level data. Data on File. 2022.
Alkharaiji M, Anyanwagu U, Donnelly R, Idris I. Tier 3 specialist weight management service and pre-bariatric multicomponent weight management programmes for adults with obesity living in the UK: a systematic review. Endocrinol Diabetes Metab. 2019;2:e00042.
Athanasiadis DI, Martin A, Kapsampelis P, Monfared S, Stefanidis D. Factors associated with weight regain post-bariatric surgery: a systematic review. Surg Endosc. 2021;35:4069–84.
National Institute of Health and Care Excellence. Committee Papers. In: Liraglutide for managing overweight and obesity. Technology appraisal guidance [TA664]. 2020. https://www.nice.org.uk/guidance/ta664/evidence. Accessed 18 Nov 2022.
Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6:944–53.
Office for National Statistics. Mortality rates (qx), males and females, ages 0 to 100, UK, England, Wales, Scotland and Northern Ireland, 1980-1982 to 2018-2020. 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies. Accessed 18 Nov 2022.
Wang HI, Han L, Jacobs R, Doran T, Holt RIG, Prady SL, et al. Healthcare resource use and costs for people with type 2 diabetes mellitus with and without severe mental illness in England: longitudinal matched-cohort study using the Clinical Practice Research Datalink. Br J Psychiatry. 2022;221:402–9.
Landi F, Calvani R, Picca A, Tosato M, Martone AM, Ortolani E, et al. Body Mass Index is Strongly Associated with Hypertension: Results from the Longevity Check-up 7+ Study. Nutrients. 2018;10:1976.
Wall H, Smith C, Hubbard R. Body mass index and obstructive sleep apnoea in the UK: a cross-sectional study of the over-50s. Prim Care Respir J. 2012;21:371–6.
Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64:1577–86.
Epstein D, Bojke L, Sculpher MJ, group Rt. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ. 2009;339:b2576.
Rowen D, Brazier J, Roberts J. Mapping SF-36 onto the EQ-5D index: how reliable is the relationship? Health Qual Life Outcomes. 2009;7:27.
Stephenson J, Smith CM, Kearns B, Haywood A, Bissell P. The association between obesity and quality of life: a retrospective analysis of a large-scale population-based cohort study. BMC Public Health. 2021;21:1990.
Hyland ME. A brief guide to the selection of quality of life instrument. Health Qual Life Outcomes. 2003;1:24.
Ara R, Wailoo A. NICE DSU Technical Support Document 12: the use of health state utility values in decision models. 2011. https://www.sheffield.ac.uk/nice-dsu/tsds/utilities. Accessed 12 Dec 2022.
Miller JD, Ye X, Lenhart GM, Farr AM, Tran OV, Kwong WJ, et al. Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US. Clinicoecon Outcomes Res. 2016;8:215–26.
Sullivan PW, Slejko JF, Sculpher MJ, Ghushchyan V. Catalogue of EQ-5D scores for the United Kingdom. Med Decis Making. 2011;31:800–4.
Worbes-Cerezo M, Nafees B, Lloyd A, Gallop K, Ladha I, Kerr C. Disutility study for adult patients with moderate to severe crohn’s disease. J Health Econ Outcomes Res. 2019;6:47–60.
Jones K, Burns A. Unit Costs of Health and Social Care 2021, Personal Social Services Research Unit, University of Kent, Canterbury. 2021.
NHS England. 2020/21 National Cost Collection Data Publication. 2022. https://www.england.nhs.uk/publication/2020-21-national-cost-collection-data-publication/.
British National Formulary. Enalapril maleate medicinal forms. 2022. https://bnf.nice.org.uk/drugs/enalapril-maleate/medicinal-forms/
British National Formulary. Lisinopril medicinal forms. 2022. https://bnf.nice.org.uk/drugs/lisinopril/medicinal-forms/
British National Formulary. Perindopril maleate medicinal forms. 2022. https://bnf.nice.org.uk/drugs/perindopril-erbumine/medicinal-forms/.
British National Formulary. Ramipril medicinal forms. 2022. https://bnf.nice.org.uk/drugs/ramipril/medicinal-forms/.
Ara R, Brazier J. Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health. 2008;11:1131–43.
Salminen P, Gronroos S, Helmio M, Hurme S, Juuti A, Juusela R, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, Comorbidities, and Reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg. 2022;157:656–66.
Kim TJ, von dem Knesebeck O. Income and obesity: what is the direction of the relationship? A systematic review and meta-analysis. BMJ Open. 2018;8:e019862.
Jordan K, Fawsitt CG, Carty PG, Clyne B, Teljeur C, Harrington P, et al. Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations. Eur J Health Econ. 2023;24:575–90.
Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, et al. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess. 2009;13:1–190.
Sharaiha R, Wilson E, Teixeira A, Thaemert B, Chapman C, Kumbhari V, et al. US commercial cost-effectiveness analysis of endoscopic sleeve gastroplasty (ESG) versus lifestyle modification (LM) alone for adults with class II obesity (abstract). Gastrointest Endosc. 2023;97:AB4.
Sharaiha RZ, Hajifathalian K, Kumar R, Saunders K, Mehta A, Ang B, et al. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin Gastroenterol Hepatol. 2021;19:1051–7.e2.
Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol. 2020;75:235–51.
Gibbs BB, Tudorascu D, Bryce CL, Comer D, Fischer GS, Hess R, et al. Lifestyle habits associated with weight regain after intentional loss in primary care patients participating in a randomized trial. J Gen Intern Med. 2020;35:3227–33.
Dombrowski SU, Knittle K, Avenell A, Araujo-Soares V, Sniehotta FF. Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials. BMJ. 2014;348:g2646.
Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014;384:755–65.
Raud B, Gay C, Guiguet-Auclair C, Bonnin A, Gerbaud L, Pereira B, et al. Level of obesity is directly associated with the clinical and functional consequences of knee osteoarthritis. Sci Rep. 2020;10:3601.
NHS England. NHS Diabetes Prevention Programme and Weight Management Services. Eligibility Criteria. NHS England Publications Gateway Reference 05140. 2016. https://www.england.nhs.uk/wp-content/uploads/2016/07/dpp-wm-service.pdf. Accessed 20 Nov. 2022.
Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006;354:2340–8.
Vusirikala A, Thomas T, Bhala N, Tahrani AA, Thomas GN, Nirantharakumar K. Impact of obesity and metabolic health status in the development of non-alcoholic fatty liver disease (NAFLD): a United Kingdom population-based cohort study using the health improvement network (THIN). BMC Endocr Disord. 2020;20:96.
Apollo Endosurgery Inc. Data on File. 2022.